Baker Bros. Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
|
|||||
|
2025
Q1 | $57.1M | Hold |
|
|||||
|
2024
Q4 | $66.3M | Hold |
|
|||||
|
2024
Q3 | $87.6M | Buy |
|
|||||
|
2024
Q2 | $60.3M | Hold |
|
|||||
|
2024
Q1 | $68.5M | Hold |
|
|||||
|
2023
Q4 | $70.1M | Buy |
|
|||||
|
2023
Q3 | $48.7M | Buy |
|
|||||
|
2023
Q2 | $36.1M | Buy |
|
|||||
|
2023
Q1 | $18.9M | Hold |
|
|||||
|
2022
Q4 | $21.8M | Hold |
|
|||||
|
2022
Q3 | $19.5M | Hold |
|
|||||
|
2022
Q2 | $28.1M | Buy |
|
|||||
|
2022
Q1 | $32.3M | Hold |
|
|||||
|
2021
Q4 | $37.4M | Hold |
|
|||||
|
2021
Q3 | $40.1M | Hold |
|
|||||
|
2021
Q2 | $42.4M | Hold |
|
|||||
|
2021
Q1 | $50.6M | Hold |
|
|||||
|
2020
Q4 | $61.5M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.55M | Sell |
|
|||||
|
2017
Q1 | $3.39M | Hold |
|
|||||
|
2016
Q4 | $3.52M | Sell |
|
|||||
|
2016
Q3 | $7.09M | Sell |
|
|||||
|
2016
Q2 | $5.42M | Sell |
|
|||||
|
2016
Q1 | $7.84M | Hold |
|
|||||
|
2015
Q4 | $13.9M | Hold |
|
|||||
|
2015
Q3 | $11.9M | Hold |
|
|||||
|
2015
Q2 | $12.7M | Sell |
|
|||||
|
2015
Q1 | $9.24M | Sell |
|
|||||
|
2014
Q4 | $6.58M | Hold |
|
|||||
|
2014
Q3 | $8.49M | Buy |
|
|||||
|
2014
Q2 | $4.49M | Hold |
|
|||||
|
2014
Q1 | $4.89M | Buy |
|